Education
About Us
Working with TipRanks
Follow Us
UnitedHealth (UNH)
NYSE:UNH
UNH Analyst Ratings
Strong Buy
22 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
UNH Stock 12 Month Forecast
Average Price Target
$629.63
▲(21.82% Upside)
| Highest Price Target$700.00 | Average Price Target$629.63 | Lowest Price Target$560.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Wells Fargo
Reiterated
03/20/25
Mizuho Securities
Reiterated
03/14/25
Deutsche Bank
Reiterated
03/05/25
J.P. Morgan
Reiterated
03/04/25
Bernstein
Reiterated
03/04/25
Stephens
Reiterated
03/03/25
Erste Group
Downgraded
02/26/25
Piper Sandler
Reiterated
02/26/25
Argus Research
Reiterated
02/25/25
Barclays
Reiterated
02/24/25
Morgan Stanley
$610
Buy
18.02%
Upside
Reiterated
02/21/25
UnitedHealth's Strategic Positioning and Valuation Justify Buy Rating Amid DOJ ScrutinyWe view the magnitude of today's move as seemingly overdone, but it admittedly adds to the growing media scrutiny around UNH and the broader MCO group, that we do not anticipate will abate anytime soon. UNH is currently trading at 15.2x, below its 3, 5, and 10 year averages (19.5x, 19.3x, and 18.2x, respectively). Relative to the diversified MCO peer group, UNH is trading at its Morgan Stanley & Co.
Leerink Partners
$675
Buy
30.60%
Upside
Reiterated
02/21/25
UnitedHealth selloff after DOJ fraud probe 'perhaps overly harsh,' says LeerinkUnitedHealth selloff after DOJ fraud probe 'perhaps overly harsh,' says Leerink
RBC Capital
$655
Buy
26.73%
Upside
Reiterated
02/21/25
Reaction to WSJ report on UnitedHealth 'overdone,' says RBC CapitalReaction to WSJ report on UnitedHealth 'overdone,' says RBC Capital
Bank of America Securities
―
Buy
―
Reiterated
02/21/25
UnitedHealth (UNH) Receives a Buy from Bank of America Securities
Cantor Fitzgerald
$700
Buy
35.44%
Upside
Reiterated
02/19/25
Cantor Fitzgerald reiterates Overweight Rating on UnitedHealth Group (UNH)Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $700.00 price target on UnitedHealth Group (NYSE: UNH).
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Wells Fargo
Reiterated
03/20/25
Mizuho Securities
Reiterated
03/14/25
Deutsche Bank
Reiterated
03/05/25
J.P. Morgan
Reiterated
03/04/25
Bernstein
Reiterated
03/04/25
Stephens
Reiterated
03/03/25
Erste Group
Downgraded
02/26/25
Piper Sandler
Reiterated
02/26/25
Argus Research
Reiterated
02/25/25
Barclays
Reiterated
02/24/25
Morgan Stanley
$610
Buy
18.02%
Upside
Reiterated
02/21/25
UnitedHealth's Strategic Positioning and Valuation Justify Buy Rating Amid DOJ ScrutinyWe view the magnitude of today's move as seemingly overdone, but it admittedly adds to the growing media scrutiny around UNH and the broader MCO group, that we do not anticipate will abate anytime soon. UNH is currently trading at 15.2x, below its 3, 5, and 10 year averages (19.5x, 19.3x, and 18.2x, respectively). Relative to the diversified MCO peer group, UNH is trading at its Morgan Stanley & Co.
Leerink Partners
$675
Buy
30.60%
Upside
Reiterated
02/21/25
UnitedHealth selloff after DOJ fraud probe 'perhaps overly harsh,' says LeerinkUnitedHealth selloff after DOJ fraud probe 'perhaps overly harsh,' says Leerink
RBC Capital
$655
Buy
26.73%
Upside
Reiterated
02/21/25
Reaction to WSJ report on UnitedHealth 'overdone,' says RBC CapitalReaction to WSJ report on UnitedHealth 'overdone,' says RBC Capital
Bank of America Securities
―
Buy
―
Reiterated
02/21/25
UnitedHealth (UNH) Receives a Buy from Bank of America Securities
Cantor Fitzgerald
$700
Buy
35.44%
Upside
Reiterated
02/19/25
Cantor Fitzgerald reiterates Overweight Rating on UnitedHealth Group (UNH)Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $700.00 price target on UnitedHealth Group (NYSE: UNH).
Best Analysts Covering UnitedHealth
Which Analyst Should I Follow If I Want to Buy UNH and Sell After:
1 Month
xxx
Success Rate
28/39 ratings generated profit
Average Return
+1.57%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 71.79% of your transactions generating a profit, with an average return of +1.57% per trade.
3 Months
xxx
Success Rate
18/24 ratings generated profit
Average Return
+5.92%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +5.92% per trade.
1 Year
Success Rate
25/28 ratings generated profit
Average Return
+19.20%
reiterated a buy rating last month
Copying Sarah James's trades and holding each position for 1 Year would result in 89.29% of your transactions generating a profit, with an average return of +19.20% per trade.
2 Years
xxx
Success Rate
28/28 ratings generated profit
Average Return
+33.61%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +33.61% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
UNH Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
0
0
0
0
Buy
31
46
47
57
47
Hold
1
1
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
32
47
47
58
48
Each month's total comprises the sum of three months' worth of ratings.
UNH Financial Forecast
UNH Stock Forecast FAQ
What is UNH’s average 12-month price target, according to analysts?
Based on analyst ratings, UnitedHealth’s 12-month average price target is $629.63.
What is UNH’s upside potential, based on the analysts’ average price target?
UnitedHealth has 21.82% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is UNH a Buy, Sell or Hold?
UnitedHealth has a consensus rating of Strong Buy which is based on 22 buy ratings, 1 hold ratings and 0 sell ratings.
What is UnitedHealth’s price target?
The average price target for UnitedHealth is $629.63. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $700.00 ,the lowest forecast is $560.00. The average price target represents 21.82% Increase from the current price of $516.85.
The highest analyst price target is $700.00 ,the lowest forecast is $560.00. The average price target represents 21.82% Increase from the current price of $516.85.
What do analysts say about UnitedHealth?
UnitedHealth’s analyst rating consensus is a Strong Buy. This is based on the ratings of 23 Wall Streets Analysts.
How can I buy shares of UNH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.